Paper36683074
Lyophilized mRNA-lipid nanoparticle vaccines with long-term stability and high antigenicity against SARS-CoV-2.
Ai L and 33 others. Cell Discov, 2023. Cited by 119 papers, by iCite.
Cite this record
ConductScience Library. Lyophilized mRNA-lipid nanoparticle vaccines with long-term stability and high antigenicity against SARS-CoV-2. Papers, record 36683074. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36683074
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Lyophilized mRNA-lipid nanoparticle vaccines with long-term stability and high antigenicity against SARS-CoV-2.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References24
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 30154315 | Lyophilization of Liposomal Formulations: Still Necessary, Still Challenging. | Pharmaceutics | 2018 | https://conductscience.org/library/papers/30154315 | PubMed |
| 2 | 18072597 | Long-term storage of DNA-free RNA for use in vaccine studies. | Biotechniques | 2007 | https://conductscience.org/library/papers/18072597 | PubMed |
| 3 | 23860045 | An efficient method for long-term room temperature storage of RNA. | Eur J Hum Genet | 2014 | https://conductscience.org/library/papers/23860045 | PubMed |
| 4 | 33400747 | Targeted liposomal drug delivery: a nanoscience and biophysical perspective. | Nanoscale Horiz | 2021 | https://conductscience.org/library/papers/33400747 | PubMed |
| 5 | 30898571 | Lyophilized liposome-based parenteral drug development: Reviewing complex product design strategies and current regulatory environments. | Adv Drug Deliv Rev | 2019 | https://conductscience.org/library/papers/30898571 | PubMed |
| 6 | 33321139 | Addressing the Cold Reality of mRNA Vaccine Stability. | J Pharm Sci | 2021 | https://conductscience.org/library/papers/33321139 | PubMed |
| 7 | 31629037 | Effective mRNA pulmonary delivery by dry powder formulation of PEGylated synthetic KL4 peptide. | J Control Release | 2019 | https://conductscience.org/library/papers/31629037 | PubMed |
| 8 | 34417582 | The mutation that helps Delta spread like wildfire. | Nature | 2021 | https://conductscience.org/library/papers/34417582 | PubMed |
| 9 | 34995482 | mRNA-based COVID-19 vaccine boosters induce neutralizing immunity against SARS-CoV-2 Omicron variant. | Cell | 2022 | https://conductscience.org/library/papers/34995482 | PubMed |
| 10 | 34131024 | SARS-CoV-2 vaccines elicit durable immune responses in infant rhesus macaques. | Sci Immunol | 2021 | https://conductscience.org/library/papers/34131024 | PubMed |
| 11 | 34952914 | Long-term stability and protection efficacy of the RBD-targeting COVID-19 mRNA vaccine in nonhuman primates. | Signal Transduct Target Ther | 2021 | https://conductscience.org/library/papers/34952914 | PubMed |
| 12 | 35131437 | Lyophilization provides long-term stability for a lipid nanoparticle-formulated, nucleoside-modified mRNA vaccine. | Mol Ther | 2022 | https://conductscience.org/library/papers/35131437 | PubMed |
| 13 | 32206737 | Long-term storage of lipid-like nanoparticles for mRNA delivery. | Bioact Mater | 2020 | https://conductscience.org/library/papers/32206737 | PubMed |
| 14 | 32978602 | Quantification of SARS-CoV-2 neutralizing antibody by a pseudotyped virus-based assay. | Nat Protoc | 2020 | https://conductscience.org/library/papers/32978602 | PubMed |
| 15 | 34811367 | A novel mechanism for the loss of mRNA activity in lipid nanoparticle delivery systems. | Nat Commun | 2021 | https://conductscience.org/library/papers/34811367 | PubMed |
| 16 | 35772405 | Antibody escape of SARS-CoV-2 Omicron BA.4 and BA.5 from vaccine and BA.1 serum. | Cell | 2022 | https://conductscience.org/library/papers/35772405 | PubMed |
| 17 | 17118485 | Freeze-drying of nanoparticles: formulation, process and storage considerations. | Adv Drug Deliv Rev | 2006 | https://conductscience.org/library/papers/17118485 | PubMed |
| 18 | 32088327 | The challenge and prospect of mRNA therapeutics landscape. | Biotechnol Adv | 2020 | https://conductscience.org/library/papers/32088327 | PubMed |
| 19 | 33839230 | mRNA-lipid nanoparticle COVID-19 vaccines: Structure and stability. | Int J Pharm | 2021 | https://conductscience.org/library/papers/33839230 | PubMed |
| 20 | 34888894 | Omicron variant genome evolution and phylogenetics. | J Med Virol | 2022 | https://conductscience.org/library/papers/34888894 | PubMed |
Cited by86
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 119 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42854694 | AI-integrated RNA therapeutics in precision oncology. | Cell Rep Med | 2026 | https://conductscience.org/library/papers/42854694 | PubMed |
| 42844249 | Bioengineering strategies for improving the immunogenicity of mRNA vaccines. | Signal Transduct Target Ther | 2026 | https://conductscience.org/library/papers/42844249 | PubMed |
| 42806112 | Accelerated discovery of thermostable mRNA-lipid nanoparticle vaccines using data-efficient AI. | Nat Biotechnol | 2026 | https://conductscience.org/library/papers/42806112 | PubMed |
| 42804114 | mRNA lipid nanoparticle vaccines: current status, challenges and future prospects. | Mol Biomed | 2026 | https://conductscience.org/library/papers/42804114 | PubMed |
| 42729695 | In vivo immune cell engineering from bench to clinical reality. | Pharm Sci Adv | 2026 | https://conductscience.org/library/papers/42729695 | PubMed |
| 42717177 | Spray Freeze Drying for Solid Formulations of RNA Lipid Nanoparticles. | AAPS PharmSciTech | 2026 | https://conductscience.org/library/papers/42717177 | PubMed |
| 42711609 | An Investigation of Water Vapor Sorption for Improving Reconstitution Pathways of Freeze-Dried Lipid Nanoparticles Stabilized by Trehalose/Mannitol Excipients. | AAPS PharmSciTech | 2026 | https://conductscience.org/library/papers/42711609 | PubMed |
| 42654139 | Microneedles for Vaccination: Mechanistic Foundations, Materials Innovation, Clinical Translation, and Global Health Implementation. | Pharmaceutics | 2026 | https://conductscience.org/library/papers/42654139 | PubMed |
| 42654026 | Next-Generation Nanocarrier Platforms for RNA Vaccines: Advances in Formulation, Stability Engineering, and Translational Manufacturing Challenges. | Pharmaceutics | 2026 | https://conductscience.org/library/papers/42654026 | PubMed |
| 42515660 | Chlorophyll-Loaded Castor Oil Nanoemulsions Exhibit Photodynamic Therapy Efficacy Against B16-F10 Melanoma with Low Cytotoxicity Toward HaCaT Keratinocytes. | Pharmaceuticals (Basel) | 2026 | https://conductscience.org/library/papers/42515660 | PubMed |
| 42514871 | Analytical Characterization and Stability Assessment of RNA-Based Vaccines. | Pharmaceutics | 2026 | https://conductscience.org/library/papers/42514871 | PubMed |
| 42353804 | Polymeric Delivery System for mRNA Therapeutics: Design Principles and Recent Advances. | Genes (Basel) | 2026 | https://conductscience.org/library/papers/42353804 | PubMed |
| 42253757 | Stabilization strategies and advancements in lyophilization to preserve integrity and efficacy of next-generation biologicals. | Int J Pharm X | 2026 | https://conductscience.org/library/papers/42253757 | PubMed |
| 42076139 | Industrial Perspective on the Manufacturing of Lipid Nanoparticles for Nucleic Acid Delivery. | Pharmaceutics | 2026 | https://conductscience.org/library/papers/42076139 | PubMed |
| 42039274 | Deciphering the biological fate of mRNA-LNP-based biologics: A perspective from tissue to intracellular distribution. | Acta Pharm Sin B | 2026 | https://conductscience.org/library/papers/42039274 | PubMed |
| 41942053 | Therapeutic peptides and proteins: Status and developments in drug delivery. | J Control Release | 2026 | https://conductscience.org/library/papers/41942053 | PubMed |
| 41893779 | Investigation on a Freeze-Drying Process for Long-Term Stability of mRNA-LNPs. | Vaccines (Basel) | 2026 | https://conductscience.org/library/papers/41893779 | PubMed |
| 41839853 | A biosafe mouse model for SARS-CoV-2 infection that more realistically simulates COVID-19 symptoms. | Signal Transduct Target Ther | 2026 | https://conductscience.org/library/papers/41839853 | PubMed |
| 41814945 | A Cryoprotectant-Compatible Nanoporous Platform for Stable and Scalable Delivery of Biopharmaceuticals. | Adv Mater | 2026 | https://conductscience.org/library/papers/41814945 | PubMed |
| 41761431 | Drug Product Development of Lipid Nanoparticle-Based mRNA Therapeutics and Vaccines. | Wiley Interdiscip Rev Nanomed Nanobiotechnol | 2026 | https://conductscience.org/library/papers/41761431 | PubMed |
Genes8
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| ACE2 | 59272 | PubTator's text mining | https://conductscience.org/library/genes/59272 | NCBI Gene |
| CD4 | 920 | PubTator's text mining | https://conductscience.org/library/genes/920 | NCBI Gene |
| CD8A | 925 | PubTator's text mining | https://conductscience.org/library/genes/925 | NCBI Gene |
| IFNG | 3458 | PubTator's text mining | https://conductscience.org/library/genes/3458 | NCBI Gene |
| IL5 | 3567 | PubTator's text mining | https://conductscience.org/library/genes/3567 | NCBI Gene |
| KRT18 | 3875 | PubTator's text mining | https://conductscience.org/library/genes/3875 | NCBI Gene |
| LBR | 3930 | PubTator's text mining | https://conductscience.org/library/genes/3930 | NCBI Gene |
| NUSAP1 | 51203 | PubTator's text mining | https://conductscience.org/library/genes/51203 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/36683074
GET https://conductscience.org/api/papers/v1/36683074/authors?page=2